Cyclacel pharmaceuticals announces participation at the h.c. wainwright 26th annual global investment conference

Berkeley heights, n.j., sept. 04, 2024 (globe newswire) -- cyclacel pharmaceuticals, inc. (nasdaq: cycc, nasdaq: cyccp; "cyclacel" or the "company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, today announced it will be featured as a presenting company at the h.c.
CYCC Ratings Summary
CYCC Quant Ranking